Becton Dickinson Newswire

Becton Dickinson Newswire

Comprehensive Real-Time News Feed for Becton Dickinson.

Results 1 - 20 of 1,489 in Becton Dickinson

  1. Becton Dickinson and's (BDX) "Buy" Rating Reiterated at Bank of AmericaRead the original story w/Photo

    12 hrs ago | AmericanBankingNews.com

    ... other equities analysts have also recently commented on the stock. Zacks Investment Research cut shares of Becton Dickinson and from a "buy" rating to a "hold" rating in a report on Friday, January 12th. Citigroup raised shares of Becton Dickinson ...

    Comment?

  2. Becton Dickinson and (BDX) Upgraded to Buy at Zacks Investment ResearchRead the original story w/Photo

    14 hrs ago | AmericanBankingNews.com

    ... reports on BDX. Bank of America reaffirmed a "buy" rating and issued a $260.00 price target on shares of Becton Dickinson and in a report on Friday. Evercore ISI began coverage on Becton Dickinson and in a report on Wednesday, January 3rd. They ...

    Comment?

  3. 3,553 Shares in Becton Dickinson and Co (BDX) Purchased by Fox Run Management L.L.C.Read the original story w/Photo

    23 hrs ago | IntersportsWire

    Fox Run Management L.L.C. bought a new stake in Becton Dickinson and Co in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 3,553 shares of the medical instruments supplier's stock, valued at approximately $761,000.

    Comment?

  4. Incredible Possibilities of Biotechnology Separation Systems Market...Read the original story w/Photo

    Yesterday | SBWire

    As the demand for biopharmaceuticals increases, we are leading the global biotechnology separation system market. As research in the life sciences continues to develop, biotechnology segregation technology has evolved significantly due to the development of new technologies.

    Comment?

  5. Global Cell Fractionation Product Industry Report Analysis with...Read the original story

    Yesterday | Emailwire.com

    Global Cell Fractionation Product Market Research Report 2018 contains historic data that spans 2013 to 2016, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in the Indus Global Cell Fractionation Product Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Cell Fractionation Product.

    Comment?

  6. Global Cell Culture Supporting Instrument Market Revenue Status and OutlookRead the original story

    Yesterday | Emailwire.com

    Global Cell Culture Supporting Instrument Market Research Report 2018 contains historic data that spans 2013 to 2016, and then continues to forecast to 2025. That makes this report so invaluable, resources, for the leaders as well as the new entrants in t Global Cell Culture Supporting Instrument Market report is replete with detailed analysis from a thorough research, especially on questions that border on market size, development environment, futuristic developments, operation situation, pathways and trend of Cell Culture Supporting Instrument.

    Comment?

  7. Characterization of Salmonella enterica from invasive bloodstream...Read the original story w/Photo

    Thursday | BioMed Central

    ... For microbiological analysis, 1-3 ml venous blood was injected into vials for paediatric blood cultures (Becton Dickinson, NJ 07417, USA) and incubated in an automated BACTEC 9050 instrument (Becton Dickinson). Broth from positive blood culture ...

    Comment?

  8. Gynecological Cancers Market to Witness Steady Expansion During 2017-2025Read the original story w/Photo

    Friday | SBWire

    ... & Africa during the forecast period. Major players operating in the global gynecological cancers market are Becton Dickinson and Co., Bristol Myers Squibb Co., Merck & Co., Pfizer, GlaxoSmithKline plc, Eli Lilly and Co., and F. Hoffmann La Roche ...

    Comment?

  9. V Wealth Management,LLC Buys Comerica Inc, The Chemours Co, Microsoft Corp, Sells First Trust ...Read the original story w/Photo

    Friday | GuruFocus.com

    Investment company V Wealth Management,LLC buys Comerica Inc, The Chemours Co, Microsoft Corp, Magna International Inc, Guggenheim CurrencyShares Japanese Yen Trust, Caterpillar Inc, Colgate-Palmolive Co, The Home Depot Inc, Johnson & Johnson, Vanguard Total International Stock ETF, sells First Trust VL Dividend, iShares Core S&P 500, iShares Core S&P Small-Cap, iShares Edge MSCI Min Vol Emerging Markets, First Trust US Equity Opportunities during the 3-months ended 2017-12-31, according to the most recent filings of the investment company, V Wealth Management,LLC. As of 2017-12-31, V Wealth Management,LLC owns 187 stocks with a total value of $182 million. These are the details of the buys and sells.

    Comment?

  10. Dental Sleep Medicine Market by 2023 - Worldwide Top Players...Read the original story w/Photo

    Friday | SBWire

    The Worldwide Dental Sleep Medicine Market Highlights The American Academy of Dental Sleep Medicine estimates that nearly 30 million adults in the U.S. are victims of obstructive sleep apnea not to mention other sleep disorders. Thus unmet medical needs coupled with rising sleep ailments is the prime driver of the market for dental sleep medicine.

    Comment?

  11. New Research Report Explore Microbial Identification Market Expected...Read the original story w/Photo

    Friday | SBWire

    This research report offers a comprehensive analysis of the " Microbial Identification Market : Food & Beverage Testing Applications to Represent Moderate Revenue Growth: Global Industry Analysis and Opportunity Assessment "The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Request to view Sample Report @ https://www.mrrse.com/sample/3738 Microbiologists adopt distinct analytical strategies for examining microbial cultures and identifying pathogens in mixed microbial communities.

    Comment?

  12. Worldwide Women Healthcare Market to Witness a Pronounce Growth by 2023Read the original story w/Photo

    Friday | SBWire

    ... of women healthcare industries are Allergan plc. (Ireland), Amgen (California), Bayer A G (Germany), Becton Dickinson and Company (U.S.), Eli Lilly Company (U.S.).Some of the other noteworthy companies Merck & Co., Inc., (U.S.), Pfizer Inc., (U.S.), ...

    Comment?

  13. Evercore ISI Group Starts Coverage On Icon (ICLR) with $126 Target;...Read the original story w/Photo

    Friday | Hill Country Times

    ... Heico Corp (NYSE:HEI) stake by 50,976 shares to 116,540 valued at $10.47M in 2017Q3. It also reduced Becton Dickinson & Co Com (NYSE:BDX) stake by 3,812 shares and now owns 68,112 shares. Jp Morgan Chase & Co (NYSE:JPM) was reduced too. Since August ...

    Comment?

  14. 1,002 Shares in Becton Dickinson and Co (BDX) Acquired by American Asset Management Inc.Read the original story w/Photo

    Friday | The Breeze

    American Asset Management Inc. acquired a new position in Becton Dickinson and Co during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,002 shares of the medical instruments supplier's stock, valued at approximately $215,000.

    Comment?

  15. Brokerages Set Becton Dickinson and Co (BDX) Price Target at $229.50Read the original story w/Photo

    Thursday | IntersportsWire

    Becton Dickinson and Co has been assigned an average recommendation of "Buy" from the seventeen analysts that are presently covering the company, MarketBeat.com reports. Five analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company.

    Comment?

  16. Endo Cutter Staplers Market Expands the Frontiers of Medical ResearchRead the original story w/Photo

    Thursday Jan 18 | SBWire

    Surgical staplers are specialized medical devices used in surgeries in place of sutures to connect or remove parts of the lungs or the bowels to close skin wounds. Surgical staplers is a recent development.

    Comment?

  17. BD Announces Completion of Enrollment in the Lutonix 014 Drug Coated Balloon Below-The-Knee TrialRead the original story w/Photo

    Thursday Jan 18 | PR Newswire

    The Lutonix BTK trial is a prospective, multicenter, randomized, controlled trial intended to demonstrate superior efficacy and non-inferior safety of the Lutonix 014 Drug Coated Balloon as compared to standard angioplasty balloon catheters for treatment of severe claudication and critical limb ischemia patients with stenotic or occlusive lesions in the below-the-knee arteries. The Lutonix BTK trial is the only on-going DCB trial for BTK arteries in the U.S. and has enrolled more than 450 patients over the past four years.

    Comment?

  18. Bank of Montreal Can Raises Position in Becton Dickinson and CoRead the original story w/Photo

    Thursday Jan 18 | Daily Political

    Bank of Montreal Can increased its position in shares of Becton Dickinson and Co by 25.5% during the fourth quarter, Holdings Channel reports. The fund owned 420,170 shares of the medical instruments supplier's stock after buying an additional 85,285 shares during the quarter.

    Comment?

  19. BD Announces Webcast of Annual Meeting of ShareholdersRead the original story w/Photo

    Monday Jan 15 | PR Newswire

    The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to better diagnose disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics.

    Comment?

  20. Pneumonia Diagnostics & Technologies Market Set to Surge Significantly During 2013-2019Read the original story w/Photo

    Wednesday Jan 17 | SBWire

    ... recommend diagnosis on the basis of symptoms. Some of the key players operating in this market space are Becton Dickinson, Affymetrix, Bio-Rad, Abbott Laboratories, Roche, Thermo Fisher Scientific, bioMeriux, DiaSorin and Novartis Diagnostics. Some ...

    Comment?